Satoshi Teshima

ST. PAUL, Minn. — With the approval of U.S Food and Drug Administration last week, St. Jude Medical Inc. launched the Ilumien Optis PCI Optimization System, a 3-D vessel reconstruction technology that will help physicians treat patients with coronary artery disease.